The Joint Corp. operates and is a franchisor and operator of chiropractic clinics in the United States. The company provides services under the franchise agreement, including training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. It operates through a network of franchised clinics, offering routine and affordable chiropractic adjustments using a private pay, non-insurance, cash-based model. The company was incorporated in 2010 and is headquartered in Scottsdale, Arizona.…
The Joint Corp. Q3 2026 Earnings Call Summary
The Joint (NASDAQ: JYNT) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 202 employees.
The shares were at 6.190 USD on 20 November 2026, down 19.3% over 52 weeks. Its 52-week range is 6.190 USD to 10.67 USD, and it trades at the bottom of that range.
At a market capitalisation of 84.74M USD, it trades at 28.1 times trailing earnings and 9.8 times forward earnings. The median trailing P/E of its 18 largest Medical Care Facilities peers is 23.8, a premium of 18% for JYNT.
The Joint reports return on equity of 19.3%, an operating margin of 6.0% and revenue up 1.3% year over year.
It holds more cash than debt, a net cash position of 16.34M USD. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 3 analysts cover the stock, with an average rating of Hold; their mean price target of 9.000 USD is 45.4% above the current price. The next earnings report is expected on 11 March 2027.